Microglial advances in psychiatric disorders.

Authors

Jemmyson R de Jesus, Iare S Ribeiro, Marcos V S Pereira, Wesley C P Aquino, Lucas H M Alfredo

Published in

Advances in immunology. Volume 171. Pages 371-400. Epub May 15, 2026.

Abstract

Psychiatric disorders constitute a major global challenge to public health, characterized by complex and multifactorial etiologies involving genetic, environmental, and neurobiological factors. In recent years, growing evidence has highlighted the central role of microglia, the resident immune cells of the central nervous system, in regulating brain homeostasis and in the pathophysiology of neuropsychiatric conditions. Beyond their classic immune functions, microglia actively participate in synaptic pruning, neurogenesis, and the modulation of neural circuits. Dysregulation of microglial activity, particularly chronic pro-inflammatory activation, has been strongly associated with disorders such as major depression, schizophrenia, bipolar disorder, and neurodegenerative diseases, contributing to impaired synaptic plasticity, neuroinflammation, and behavioral dysfunction. This chapter discusses recent advances in microglial biology, emphasizing its functional heterogeneity and dynamic phenotypic states. This chapter explores the main molecular pathways involved in microglia-mediated synaptic remodeling and their implications for the progression of neuropsychiatric disorders. Furthermore, emerging therapeutic strategies targeting microglia were discussed, including anti-inflammatory approaches, functional reprogramming, neuromodulation techniques, and microglial replacement or niche engineering. These advances support a paradigm shift from indiscriminate microglia inhibition to the precise modulation of specific functional states. Understanding and targeting microglia dynamics may provide innovative and more effective therapeutic pathways for the treatment of psychiatric disorders.

PMID:
42629132
Bibliographic data and abstract were imported from PubMed on 22 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.